Assessment of regional resistance distribution using computational fluid dynamics in cystic fibrosis patients

J. De Backer, W. Vos, A. Devolder, S. Verhust, K. Desager, W. De Backer (Antwerp, Belgium)

Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Session: Cystic fibrosis lung disease: what do we measure? What do we know?
Session type: Electronic Poster Discussion
Number: 349
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. De Backer, W. Vos, A. Devolder, S. Verhust, K. Desager, W. De Backer (Antwerp, Belgium). Assessment of regional resistance distribution using computational fluid dynamics in cystic fibrosis patients. Eur Respir J 2007; 30: Suppl. 51, 349

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013

Longitudinal changes in lung function and the association with pulmonary structure and infection in infants with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008

Single-breath washout and association with structural lung changes in children with cystic fibrosis
Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease
Year: 2016


Lung clearance Index changes over time among patients with cystic fibrosis
Source: International Congress 2015 – New findings in paediatric respiratory physiology
Year: 2015


Ability of lung clearance index to track changes in a routine clinical CF setting
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015

Longitudinal course of clinically measured lung clearance index in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Underestimation of lung clearance index values in infants with cystic fibrosis due to software analysis algorithms
Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects
Year: 2015

Lung function parameters influence serum concentration after antibiotic inhalation in patients with cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 537s
Year: 2001

A mathematical model to understand the airway clearance in cystic fibrosis
Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children
Year: 2019

Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019
Year: 2020



Relationship between airflow limitation and lung volume in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 301s
Year: 2002

Changes in ventilatory mechanics with increasing disease severity in children and adolesecents with cystic fibrosis (CF)
Source: Eur Respir J 2002; 20: Suppl. 38, 209s
Year: 2002

Long-term course of lung clearance index among patients with cystic fibrosis
Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment
Year: 2020


Assessment of the work of breathing (sWOB) within different functional and genetic groups in patients with cystic fibrosis (CF)
Source: Annual Congress 2013 –New perspectives of lung function assessment in children
Year: 2013



Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012


Improvement in pulmonary function after IV antibiotic treatment in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 342s
Year: 2002

Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010

New algorithm of antibiotic selection reveals the abundance and reduces bacterial load in sputum of adult patients with cystic fibrosis.
Source: Virtual Congress 2021 – Cystic fibrosis
Year: 2021


Progression of lung involvement in patients with cystic fibrosis (CF), assessed by longitudinal respiratory function measurements
Source: Eur Respir J 2002; 20: Suppl. 38, 20s
Year: 2002